Absence of long-range diffusion of OmpA in E. coliis not caused by its peptidoglycan binding domain
© Verhoeven et al.; licensee BioMed Central Ltd. 2013
Received: 23 December 2012
Accepted: 18 March 2013
Published: 23 March 2013
It is widely believed that integral outer membrane (OM) proteins in bacteria are able to diffuse laterally in the OM. However, stable, immobile proteins have been identified in the OM of Escherichia coli. In explaining the observations, a hypothesized interaction of the immobilized OM proteins with the underlying peptidoglycan (PG) cell wall played a prominent role.
OmpA is an abundant outer membrane protein in E. coli containing a PG-binding domain. We use FRAP to investigate whether OmpA is able to diffuse laterally over long-range (> ~100 nm) distances in the OM. First, we show that OmpA, containing a PG binding domain, does not exhibit long-range lateral diffusion in the OM. Then, to test whether PG interaction was required for this immobilization, we genetically removed the PG binding domain and repeated the FRAP experiment. To our surprise, this did not increase the mobility of the protein in the OM.
OmpA exhibits an absence of long-range (> ~100 nm) diffusion in the OM that is not caused by its PG binding domain. Therefore, other mechanisms are needed to explain this observation, such as the presence of physical barriers in the OM, or strong interactions with other elements in the cell envelope.
KeywordsBacterial cell wall Peptidoglycan Outer membrane Diffusion FRAP Cell membrane OmpA
Little information exists on the mobility of (integral) outer membrane proteins (OMPs) in the bacterial OM. Traditionally, the bacterial outer membrane is presented as a tight, gel-like barrier, with LPS packed together with cations in a crystalline matrix [1, 2]. At the same time, experimental evidence suggests that integral outer membrane protein IcsA is able to diffuse laterally over micron-ranges in the OM . Recent developments in live-cell protein labeling and (fluorescent) imaging technology are starting to elucidate the nature of protein dynamics in the bacterial OM.
For example, recent work on the mobility of integral OMP LamB suggests that it is confined to a region of size ~50 nm [4, 5]. This was based on the motion of a marker bead or quantum dot attached to a surface-exposed biotinylated loop of LamB. The authors propose that the confinement is caused by LamB’s attachment to the peptidoglycan layer (PG) layer . Furthermore, in pioneering experiments, proteins in the cell envelope of E. coli have been labeled using a reactive fluorescent dye [7, 8]. It was found that the mobility of (at least some) cell envelope proteins was restrained at the cellular poles . Also, it was found that the cell envelope contained both mobile and immobile proteins [7, 8]. It should be noted that “immobile” in this context refers to the absence of long-range (> ~100 nm) diffusion, as only single-molecule techniques have sufficient spatial resolution to detect the complete absence of diffusion over short-range distances (below ~100 nm).
In  it was speculated that one of the major OM proteins of E. coli, OmpA, would be one of the “immobile” proteins in the OM due to its PG binding domain. The PG interaction of OmpA originates from a separate C-terminal domain in the bacterial periplasm, and genetically truncated OmpA-177 consisting of only the TM domain assembles into the outer membrane as efficiently as the full-length protein [9, 10]. In this study, we have exploited these features of OmpA to determine its mobility in vivo using fluorescence recovery after photobleaching (FRAP), as well as to establish whether the presence of the PG binding domain has an effect on the mobility of the OmpA TM domain.
FRAP is a relatively simple technique to measure mobility and diffusion of fluorescent proteins inside living cells. For E. coli, it has been used to measure diffusion constants for GFP in the cytoplasm and periplasm [11, 12], as well as for various GFP fusions to inner membrane proteins [12–14].
The full-length, processed OmpA protein (325 residues) consists of two domains, an N-terminal transmembrane (TM) domain of 170 residues, connected via a short 19-residue Ala-Pro rich hinge region to a C-terminal periplasmic domain of 136 residues . The periplasmic domain plays a structural role by non-covalently tethering the OM to the peptidoglycan cell wall layer . For a comprehensive review on OmpA structure and function see .
We have taken advantage from the availability of a red fluorescent protein reporter (mCherry, ) that fluoresces in the periplasm of E. coli[19–21] to create fluorescent OmpA variants with and without PG binding domain. We used the by-now standard approach of elongating the bacterial cells using the antibiotic cephalexin [8, 11, 12].
We find that full-length OmpA exhibits an absence of long-range (> 100 nm) diffusion in the OM. Surprisingly, removing the PG binding domain genetically does not increase protein mobility. From this we conclude that the absence of long-range diffusion of OmpA is not caused by its PG binding domain.
Results and discussion
Functionality of the constructs
In previous work, we have shown that full-length OmpA with a small C-terminal linker (LEDPPAEF), as well as truncated OmpA with an epitope tag (SA-1, ) inserted in the first surface-exposed loop, expressed from plasmid in the presence of wild-type OmpA, are properly assembled into the outer membrane .
Strains and plasmids
LMC500 (MC4100 lysA)
F, araD139, Δ (argF-lac)U169, deoC1, flbB5301, ptsF25, rbsR, relA1, rpslL150, lysA1
F, endA1, hsdR17(rk mk+), supE44, thi-1, recA1, gyrA, relA1, Δ (lacZYA-argF)U169, deoR, Ф80 lacZΔ M15
DH5α LacIq+ TetR+
pTRC99A with a weakened IPTG inducible promoter
Cells are grown in EZ defined rich medium  (see also Methods), with 0.2% glucose as carbon source. We refer to this medium as DRu (defined rich glucose) medium from now on. No adverse effects on growth rate were observed for either construct under the experimental growth and induction conditions reported here.
The cells are grown in the presence of IPTG to induce expression of the construct. After staining with fluorescent Streptavidin, we find that the SA-1 peptide is properly exposed on the cell surface (Figure 1A), suggesting that the OmpA TM domain is properly inserted in the OM, with the mCherry domain present in the periplasm.
We used SDS-PAGE gel-shift experiments to check if the constructs are intact or suffer from degradation, and if so to what extent. These experiments make use of OmpA’s so-called heat modifiability : In its folded form, OmpA migrates to a different position in SDS-PAGE compared to its (heat denatured) unfolded form [9, 10].
First, we checked for a possible heat-modifiability of mCherry, as it also has a β-barrel fold. To this end, we grew cells expressing cytoplasmic mCherry, lysed them by sonication, and after varying heat treatment, subjected the samples to SDS-PAGE followed by immunoblotting with a monoclonal antibody (anti-DsRed, Clontech) that recognizes only denatured DsRed variants, including mCherry (Figure 1B). Thus, we make use of the antibody’s specificity for the unfolded state of mCherry to obtain information on its folding state after varying heat treatment conditions. A band of the expected height (27 kDa) was present that increased in intensity upon heating (the faint band above it was also present in lysate without mCherry), and did not exhibit heat-modifiability. The increase in intensity is explained by a gradual unfolding of mCherry due to increasing exposure to heat. If we assume that after boiling, all mCherry is unfolded, we then conclude based on band intensities that at RT i.e. without any heat treatment, ~80% of mCherry is folded and 20% is not. Since mCherry unfolds partially under conditions where OmpA is fully stable (15 minutes at 50°C, ), we conclude that the mCherry β-barrel fold is less stable than that of the OmpA TM domain (Figure 1B). Therefore, the anti-DsRed can be used to determine the folding state of the OmpA TM domain, because the denatured mCherry will become visible before OmpA has unfolded, and any gel-shifts observed can be unequivocally attributed to the OmpA TM domain, because mCherry itself becomes visible only after it has unfolded, and does not exhibit heat modifiability.
To test the heat-modifiability of the OmpA-177-(SA-1)-mCherry fusion, an immunoblot containing cell lysates heated at different temperatures was probed with anti-DsRed (shown in Figure 1C). Starting at the far right lane (99°C), two bands are visible, a low and high molecular weight band (LMW and HMW respectively). At RT and 37°C, only a faint LMW (degradation) band at 26 kDa was detected. At 50°C, folded mCherry starts to unfold, and the fusion becomes visible on blot. From literature  and our own experiments, we know that the folded OmpA TM domain does not unfold at all at 50°C. Increasing the temperature further from 50°C to 99°C, the OmpA TM domain unfolds and the intact fusion (HMW band) shifts to its expected molecular weight of 49 kDa. These results demonstrate that the OmpA TM domain remains heat-modifiable and therefore is correctly assembled into the OM when mCherry is fused to its C-terminus.
With increasing exposure to heat, the initially faint LMW (degradation) band also increased in intensity, and displays the exact same heat-modifiability behavior as the intact fusion between the OmpA β-barrel and mCherry. Because we know that mCherry does not exhibit heat-modifiability, the degradation band must consist of the OmpA β-barrel with (based on a MW of 28 kDa and assuming C-terminal degradation) the N-terminal part of mCherry (~55 residues), which appears to contain the epitope recognized by the monoclonal antibody. We conclude that cells expressing OmpA-177-SA-1-mCherry contain a mixture of intact fusion assembled in the OM, and OmpA-177-SA-1 with a C-terminal part of mCherry proteolytically removed. Assuming C-terminal degradation, the removed part then contains the chromophore , and therefore this would represent a dark sub-population of OmpA TM domain in the OM.
For the full-length OmpA-mCherry fusion (pGI10), we already knew that the full-length OmpA with C -terminal linker, but without mCherry (pGI9), was inserted properly in the OM . Therefore, we only checked that the mCherry fluorescence was associated with the PG/OM layer by fluorescence microscopy of plasmolyzed cells (Figure 2) . This was indeed the case.
FRAP results on cytoplasmic mCherry
To maximize the likelihood of observing OmpA mobility, we avoided the cell poles (poles contain inert PG and retain some OM proteins ) and performed the FRAP experiments in the cylindrical part of elongated cells. To create elongated cells (filaments) we grew the cells in the presence of the antibiotic cephalexin which blocks cell division but allows further elongation [11, 12]. The effect of cephalexin on bacterial cells is well-known: it binds with high affinity to PBP3, interfering with its ability to function in cell division. In addition, it has recently been shown that PBP3 only interacts with PBP2 (part of the protein complex responsible for elongation) during division at mid-cell . We expect therefore that the structure of the cell wall in filaments will be highly similar to that of normal length cells.
FRAP results on full-length OmpA-mCherry
As we were interested in diffusion / mobility of OmpA in the OM, and our timescale of observation is tens of minutes, we risked mistaking OmpA synthesis, OM insertion and / or fluorophore maturation for fluorescence recovery caused by lateral diffusion. To minimize this risk we adopted the following procedure: First the cells were grown to steady state in DRu medium in the presence of IPTG to induce expression (“pulse”), followed by resuspension of the cells in medium without IPTG to repress new synthesis (“chase”). Growing the cells in DRu medium for an additional 2 hours in the absence of IPTG allows time for export to finish and the mCherry fluorophore to mature. This way, we expected to end up with cells that contain little precursor or partially degraded protein. Then we transfered the filaments to the observation chamber (DRu-agar with ampicillin and cephalexin) and performed the FRAP experiment at room temperature. We made use of the Perfect Focus System that is part of the Nikon Eclipse Ti microscope system to keep the filament in focus during the experiment, which takes about 15–20 min per filament (N = 9).
FRAP results on truncate OmpA-177-SA-1-mCherry
To conclude, we have observed that the OmpA-177 TM domain fused to mCherry, as well as full-length OmpA fused to mCherry, exhibit an absence of long-range (> ~100 nm) diffusion in the OM on a timescale of tens of minutes. Such absence of long-range lateral diffusion has been observed before, and PG interaction was invoked in explaining (part of) these observations [4, 7, 8]. Our results imply that other mechanisms are needed to explain our observations.
It is well established that OmpA is a monomer, in contrast to many other outer membrane proteins . Immobilization through association with the endogenous OmpA proteins (that still contain a PG binding domain) can therefore not explain our observations. Possibly, an interaction with immobile LPS is responsible for the immobilization . An alternative explanation could be the existence of sub-micron size domains in the OM acting as barriers to diffusion. Interestingly, recent in vivo single molecule fluorescence experiments performed for OMP’s OmpF and BtuB implied that OmpF diffused within domains of ~100 nm in the OM, and that on average, BtuB traversed 190 nm in 0.25 s, the longest time-scale for which results were reported .
It will be interesting to see whether the short-range diffusive properties of our constructs differ. This could be investigated using single-molecule techniques. Finally, we believe that our experimental design forms a valuable addition to existing techniques to study OM protein mobility, such as FRAP after chemical labeling treatments , tracking of single molecule fluorescence [35, 36] as well as single particle tracking [4, 5].
Strains and constructs
E. coli strains (Table 1) were grown at 37°C in TY medium containing 1% Bacto trypton, 0.5% Bacto yeast extract, 0.5% NaCl and 3 mM NaOH (for cloning and pre-cultures). For the FRAP experiments, strains were grown in defined rich medium with 0.2% glucose as the carbon source (Teknova M2105 Kit) and supplemented with 1 mM thiamine-HCl (Sigma). All constructs (Table 1) were cloned into a pTrc99A vector (Pharmacia Biotech, USA), a pBR322 derivative plasmid, of which the trc promoter was modified with a down mutation to reduce expression levels . For induction conditions, cells were grown for an extended period (~15 hours) while keeping the OD550 below 0.2 in the continuous presence of 0.1 mM IPTG. Ampicillin (100 μg/ml) was used to maintain plasmids. LMC500 (MC4100 lysA) was made chemically competent using the calcium chloride method.
All DNA manipulation, analysis and bacterial transformations were performed according to standard protocols . All PCR fragments were sequenced at the AMC DNA sequencing facility (Amsterdam Medical Centre).
DNA primers used in this study
Cells are grown for ~15 hours to exponential phase in EZ defined Rich glucose (DRu) medium with 100 μM IPTG at 28°C (“pulse”). Then at OD550 < 0.2, cells are washed two times with DRu medium, and diluted to OD~0.05. Cephalexin and ampicillin are added at a concentration of 10 and 100 μg/ml respectively and the cells are grown for an additional 2 hours (“chase”). Then, the filaments are incubated for 30 min at room temperature. Imaging is at room temperature. The sample consists of two object slides, one of which has an oval shape mechanically cut out, stuck together using vacuum grease (see also ). Molten DRu agar containing cephalexin and ampicillin is poured inside, and a silanized cover slip is added to create a flat agar surface. After the agar has solidified, the silanized slip is removed, the agar is allowed to dry in for 5 min, before 2 × 5 μl cells are pipetted on the agar. Finally, a chromo-sulfuric acid cleaned cover slip is placed on top and fixed in place with vacuum grease. This creates a sealed chamber with the elongated cells lying on the agar, and the imaging is through the cover slip. The setup consists of a Nikon Eclipse Ti inverted TIRF/epi microscope equipped with a MAG Biosystems FRAP-3D unit and a Photometrics QuantEM 512SC EM-CCD camera (Roper Scientific), controlled with Metamorph software. A laser system provides green light at 561 nm. Typical FRAP setting is 100% power, duration 5–50 ms. Imaging mode is TIRF in epi-mode (TIRF angle ~90°), Nikon’s Perfect Focusing System (PFS) is used to keep filament in focus during the time-lapse imaging after bleaching. We verified with z-stacks containing slices of ~100 nm that both sides of the bacterium were bleached and imaged. Acquisition rate was every 0.5-10 s, depending on the experiment. Exposure times are typically 100–300 ms.
The raw image TIFF stack (16 bit) is cropped, and (if necessary) registered using the ImageJ plug-in Stackreg (Rigid body setting), and rotated such that the filament long axis is aligned with the square ROI. Then, a square ROI of 4 × 44 pixels (1,5x lens) is used to quantify background signal (in a region without cell), a reference signal (a part of the filament that is not bleached) and the FRAP signal, the location where the fluorescence is bleached away. The average pixel intensity of the ROI is used. The ImageJ Multi-measure plug-in is used to measure all three ROIs for a single stack. The background is subtracted from both the reference and FRAP ROI. For the analysis of images taken with the 1x lens (Figure 3) a smaller region of 2 × 28 was chosen. The pixel size was ~100 nm.
Cell fractionation, SDS-PAGE and immunoblots
For preparation of cell lysates, fractionation of cell lysates and immunoblots, see also . For SDS-PAGE, samples were mixed with sample buffer (end concentration: 62.5 mM Tris pH 6.8, 2% SDS, 10% glycerol, 2% 2-mercaptoethanol), received heat treatment varying from incubation at RT to heating to 99°C for 5 min, and were finally electrophoresed on 15% polyacrylamide slabs. The bio-rad semi-dry blotting apparatus was used for immunoblotting. The anti-dsRed monoclonal antibody (#632392, Living colors series) was purchased from Clontech. The bands were detected using the ECL+ chemiluminescence kit (Amersham) and scanning with the STORM 860 fluorescence imager.
The protocol was taken from . Overnight cultures of LMC500 cells expressing pGI10 were diluted 100x and grown for ~3 hours to an OD600 of ~0.5. Cells were grown in the absence of the inducer. 2x 500 μl cells were transferred to eppies. To prepare cells for fluorescence microscopy, 0.5 ml of culture was pelleted and resuspended in 10 μl of Luria-Bertani medium (control) or 10 μl of plasmolysis solution (15% sucrose, 25 mM HEPES [pH 7.4], 20 mM NaN3). One microliter of control cells or plasmolyzed cells was immobilized on a thin layer of 1% TY agarose or of 1% agarose in 15% sucrose in HEPES (to maintain plasmolysis), respectively. Live cells were visualized by epifluorescence microscopy within 15 min of slide preparation with a Olympus BX microscope equipped with a Coolsnap FX charge-coupled device camera.
Support was obtained from the NWO program “From Molecule to Cell” (grant 805 47 200). Genison Isijk is acknowledged for help with DNA cloning and plasmolysis. This work is part of the research program of the “Stichting voor Fundamenteel Onderzoek der Materie (FOM)”, which is financially supported by the “Nederlandse organisatie voor Wetenschappelijke Onderzoek (NWO)”.
- Nikaido H: Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev. 2003, 67: 593-656. 10.1128/MMBR.67.4.593-656.2003.PubMedPubMed CentralView ArticleGoogle Scholar
- Ruiz N, Kahne D, Silhavy TJ: Advances in understanding bacterial outer-membrane biogenesis. Nat Rev Microbiol. 2006, 4: 57-66. 10.1038/nrmicro1322.PubMedView ArticleGoogle Scholar
- Robbins JR, Monack D, McCallum SJ, Vegas A, Pham E, Goldberg MB, Theriot JA: The making of a gradient: IcsA (VirG) polarity in Shigella flexneri. Mol Microbiol. 2001, 41: 861-872.PubMedView ArticleGoogle Scholar
- Oddershede L, Dreyer JK, Grego S, Brown S, Berg-Sorensen K: The motion of a single molecule, the lambda-receptor, in the bacterial outer membrane. Biophys J. 2002, 83: 3152-3161. 10.1016/S0006-3495(02)75318-6.PubMedPubMed CentralView ArticleGoogle Scholar
- Winther T, Xu L, Berg-Sørensen K, Brown S, Oddershede LB: Effect of energy metabolism on protein motility in the bacterial outer membrane. Biophys J. 2009, 97: 1305-12. 10.1016/j.bpj.2009.06.027.PubMedPubMed CentralView ArticleGoogle Scholar
- Gabay J, Yasunaka K: Interaction of the lamB protein with the peptidoglycan layer in Escherichia coli K12. Eur J Biochem. 1980, 104: 13-18. 10.1111/j.1432-1033.1980.tb04393.x.PubMedView ArticleGoogle Scholar
- De Pedro MA, Grunfelder CG, Schwarz H: Restricted mobility of cell surface proteins in the polar regions of Escherichia coli. J Bacteriol. 2004, 186: 2594-2602. 10.1128/JB.186.9.2594-2602.2004.PubMedPubMed CentralView ArticleGoogle Scholar
- Ghosh AS, Young KD: Helical disposition of proteins and lipopolysaccharide in the outer membrane of Escherichia coli. J Bacteriol. 2005, 187: 1913-1922. 10.1128/JB.187.6.1913-1922.2005.PubMedPubMed CentralView ArticleGoogle Scholar
- Ried G, Koebnik R, Hindennach I, Mutschler B, Henning U: Membrane topology and assembly of the outer membrane protein OmpA of Escherichia coli K12. Mol Gen Genet. 1994, 243: 127-135.PubMedGoogle Scholar
- Verhoeven GS, Alexeeva S, Dogterom M, Den Blaauwen T: Differential bacterial surface display of peptides by the transmembrane domain of OmpA. PLoS One. 2009, 4: e6739-10.1371/journal.pone.0006739.PubMedPubMed CentralView ArticleGoogle Scholar
- Elowitz MB, Surette MG, Wolf PE, Stock JB, Leibler S: Protein mobility in the cytoplasm of Escherichia coli. J Bacteriol. 1999, 181: 197-203.PubMedPubMed CentralGoogle Scholar
- Mullineaux CW, Nenninger A, Ray N, Robinson C: Diffusion of green fluorescent protein in three cell environments in Escherichia coli. J Bacteriol. 2006, 188: 3442-3448. 10.1128/JB.188.10.3442-3448.2006.PubMedPubMed CentralView ArticleGoogle Scholar
- Ray N, Nenninger A, Mullineaux CW, Robinson C: Location and mobility of twin arginine translocase subunits in the Escherichia coli plasma membrane. J Biol Chem. 2005, 280: 17961-17968.PubMedView ArticleGoogle Scholar
- Lenn T, Leake MC, Mullineaux CW: Clustering and dynamics of cytochrome bd-I complexes in the Escherichia coli plasma membrane in vivo. Mol Microbiol. 2008, 70: 1397-1407. 10.1111/j.1365-2958.2008.06486.x.PubMedView ArticleGoogle Scholar
- Chen R, Schmidmayr W, Kramer C, Chen-Schmeisser U, Henning U: Primary structure of major outer membrane protein II (ompA protein) of Escherichia coli K-12. Proc Natl Acad Sci USA. 1980, 77: 4592-4596. 10.1073/pnas.77.8.4592.PubMedPubMed CentralView ArticleGoogle Scholar
- Grizot S, Buchanan SK: Structure of the OmpA-like domain of RmpM from Neisseria meningitidis. Mol Microbiol. 2004, 51: 1027-1037. 10.1111/j.1365-2958.2003.03903.x.PubMedView ArticleGoogle Scholar
- Smith SG, Mahon V, Lambert MA, Fagan RP: A molecular Swiss army knife: OmpA structure, function and expression. FEMS Microbiol Lett. 2007, 273: 1-11. 10.1111/j.1574-6968.2007.00778.x.PubMedView ArticleGoogle Scholar
- Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY: Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol. 2004, 22: 1567-1572. 10.1038/nbt1037.PubMedView ArticleGoogle Scholar
- Chen JC, Viollier PH, Shapiro L: A membrane metalloprotease participates in the sequential degradation of a Caulobacter polarity determinant. Mol Microbiol. 2005, 55: 1085-1103.PubMedView ArticleGoogle Scholar
- Gerding MA, Ogata Y, Pecora ND, Niki H, De Boer PA: The trans-envelope Tol-Pal complex is part of the cell division machinery and required for proper outer-membrane invagination during cell constriction in E. coli. Mol Microbiol. 2007, 63: 1008-1025. 10.1111/j.1365-2958.2006.05571.x.PubMedPubMed CentralView ArticleGoogle Scholar
- Buddelmeijer N, Krehenbrink M, Pecorari F, Pugsley AP: Type II secretion system secretin PulD localizes in clusters in the Escherichia coli outer membrane. J Bacteriol. 2009, 191: 161-168. 10.1128/JB.01138-08.PubMedPubMed CentralView ArticleGoogle Scholar
- Bessette PH, Rice JJ, Daugherty PS: Rapid isolation of high-affinity protein binding peptides using bacterial display. Protein Eng Des Sel. 2004, 17: 731-739. 10.1093/protein/gzh084.PubMedView ArticleGoogle Scholar
- Taschner PE, Huls PG, Pas E, Woldringh CL: Division behavior and shape changes in isogenic ftsZ, ftsQ, ftsA, pbpB, and ftsE cell division mutants of Escherichia coli during temperature shift experiments. J Bacteriol. 1988, 170: 1533-1540.PubMedPubMed CentralGoogle Scholar
- Lutz R, Bujard H: Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res. 1997, 25: 1203-1210. 10.1093/nar/25.6.1203.PubMedPubMed CentralView ArticleGoogle Scholar
- Alexeeva S, Gadella TWJ, Verheul J, Verhoeven GS, Den Blaauwen T: Direct interactions of early and late assembling division proteins in Escherichia coli cells resolved by FRET. Mol Microbiol. 2010, 77: 384-98. 10.1111/j.1365-2958.2010.07211.x.PubMedView ArticleGoogle Scholar
- Den Blaauwen T, Aarsman ME, Vischer NO, Nanninga N: Penicillin-binding protein PBP2 of Escherichia coli localizes preferentially in the lateral wall and at mid-cell in comparison with the old cell pole. Mol Microbiol. 2003, 47: 539-547. 10.1046/j.1365-2958.2003.03316.x.PubMedView ArticleGoogle Scholar
- Neidhardt FC, Bloch PL, Smith DF: Culture medium for enterobacteria. J Bacteriol. 1974, 119: 736-747.PubMedPubMed CentralGoogle Scholar
- Thomas JD, Daniel RA, Errington J, Robinson C: Export of active green fluorescent protein to the periplasm by the twin-arginine translocase (Tat) pathway in Escherichia coli. Mol Microbiol. 2001, 39: 47-53. 10.1046/j.1365-2958.2001.02253.x.PubMedView ArticleGoogle Scholar
- Reithmeier RA, Bragg PD: Purification and characterization of heat-modifiable protein from the outer membrane of Escherichia coli. FEBS Lett. 1974, 41: 195-198. 10.1016/0014-5793(74)81210-X.PubMedView ArticleGoogle Scholar
- Shaner NC, Patterson GH, Davidson MW: Advances in fluorescent protein technology. J Cell Sci. 2007, 120: 4247-4260. 10.1242/jcs.005801.PubMedView ArticleGoogle Scholar
- Lewenza S, Vidal-Ingigliardi D, Pugsley AP: Direct visualization of red fluorescent lipoproteins indicates conservation of the membrane sorting rules in the family Enterobacteriaceae. J Bacteriol. 2006, 188: 3516-3524. 10.1128/JB.188.10.3516-3524.2006.PubMedPubMed CentralView ArticleGoogle Scholar
- Van der Ploeg R, Verheul J, Vischer NOE, Alexeeva S, Hoogendoorn E, Postma M, Banzhaf M, Vollmer W, Den Blaauwen T: Colocalization and interaction between elongasome and divisome during a preparative cell division phase in Escherichia coli. Mol Microbiol. 2013, 87: 1074-1087. 10.1111/mmi.12150.PubMedView ArticleGoogle Scholar
- De Pedro MA, Quintela JC, Holtje JV, Schwarz H: Murein segregation in Escherichia coli. J Bacteriol. 1997, 179: 2823-2834.PubMedPubMed CentralGoogle Scholar
- Reusch RN: Insights into the structure and assembly of Escherichia coli outer membrane protein a. FEBS J. 2012, 279: 894-909. 10.1111/j.1742-4658.2012.08484.x.PubMedPubMed CentralView ArticleGoogle Scholar
- Spector J, Zakharov S, Lill Y, Sharma O, Cramer WA, Ritchie K: Mobility of BtuB and OmpF in the Escherichia coli outer membrane: implications for dynamic formation of a translocon complex. Biophys J. 2010, 99: 3880-6. 10.1016/j.bpj.2010.10.029.PubMedPubMed CentralView ArticleGoogle Scholar
- Ritchie K, Spector J: Single molecule studies of molecular diffusion in cellular membranes: determining membrane structure. Biopolymers. 2007, 87: 95-101. 10.1002/bip.20801.PubMedView ArticleGoogle Scholar
- Sambrook J, Russel DW: Molecular cloning: a laboratory manual. 2001, Third edition. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory PressGoogle Scholar
- Adiciptaningrum AM, Blomfield IC, Tans SJ: Direct observation of type 1 fimbrial switching. EMBO Rep. 2009, 10: 527-32. 10.1038/embor.2009.25.PubMedPubMed CentralView ArticleGoogle Scholar